About us
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Our Strategic Road Map defines strategies, standards, and policy frameworks to support responsible global use of genomic and related health data.
Discover how a meeting of 50 leaders in genomics and medicine led to an alliance uniting more than 5,000 individuals and organisations to benefit human health.
GA4GH Inc. is a not-for-profit organisation that supports the global GA4GH community.
The GA4GH Council, consisting of the Executive Committee, Strategic Leadership Committee, and Product Steering Committee, guides our collaborative, globe-spanning alliance.
The Funders Forum brings together organisations that offer both financial support and strategic guidance.
The EDI Advisory Group responds to issues raised in the GA4GH community, finding equitable, inclusive ways to build products that benefit diverse groups.
Distributed across a number of Host Institutions, our staff team supports the mission and operations of GA4GH.
Curious who we are? Meet the people and organisations across six continents who make up GA4GH.
More than 500 organisations connected to genomics — in healthcare, research, patient advocacy, industry, and beyond — have signed onto the mission and vision of GA4GH as Organisational Members.
These core Organisational Members are genomic data initiatives that have committed resources to guide GA4GH work and pilot our products.
This subset of Organisational Members whose networks or infrastructure align with GA4GH priorities has made a long-term commitment to engaging with our community.
Local and national organisations assign experts to spend at least 30% of their time building GA4GH products.
Anyone working in genomics and related fields is invited to participate in our inclusive community by creating and using new products.
Wondering what GA4GH does? Learn how we find and overcome challenges to expanding responsible genomic data use for the benefit of human health.
Study Groups define needs. Participants survey the landscape of the genomics and health community and determine whether GA4GH can help.
Work Streams create products. Community members join together to develop technical standards, policy frameworks, and policy tools that overcome hurdles to international genomic data use.
GIF solves problems. Organisations in the forum pilot GA4GH products in real-world situations. Along the way, they troubleshoot products, suggest updates, and flag additional needs.
NIF finds challenges and opportunities in genomics at a global scale. National programmes meet to share best practices, avoid incompatabilities, and help translate genomics into benefits for human health.
Communities of Interest find challenges and opportunities in areas such as rare disease, cancer, and infectious disease. Participants pinpoint real-world problems that would benefit from broad data use.
The Technical Alignment Subcommittee (TASC) supports harmonisation, interoperability, and technical alignment across GA4GH products.
Find out what’s happening with up to the minute meeting schedules for the GA4GH community.
See all our products — always free and open-source. Do you work on cloud genomics, data discovery, user access, data security or regulatory policy and ethics? Need to represent genomic, phenotypic, or clinical data? We’ve got a solution for you.
All GA4GH standards, frameworks, and tools follow the Product Development and Approval Process before being officially adopted.
Learn how other organisations have implemented GA4GH products to solve real-world problems.
Help us transform the future of genomic data use! See how GA4GH can benefit you — whether you’re using our products, writing our standards, subscribing to a newsletter, or more.
Help create new global standards and frameworks for responsible genomic data use.
Align your organisation with the GA4GH mission and vision.
Want to advance both your career and responsible genomic data sharing at the same time? See our open leadership opportunities.
Join our international team and help us advance genomic data use for the benefit of human health.
Share your thoughts on all GA4GH products currently open for public comment.
Solve real problems by aligning your organisation with the world’s genomics standards. We offer software dvelopers both customisable and out-of-the-box solutions to help you get started.
Learn more about upcoming GA4GH events. See reports and recordings from our past events.
Speak directly to the global genomics and health community while supporting GA4GH strategy.
Be the first to hear about the latest GA4GH products, upcoming meetings, new initiatives, and more.
Questions? We would love to hear from you.
Read news, stories, and insights from the forefront of genomic and clinical data use.
Attend an upcoming GA4GH event, or view meeting reports from past events.
See new projects, updates, and calls for support from the Work Streams.
Read academic papers coauthored by GA4GH contributors.
Listen to our podcast OmicsXchange, featuring discussions from leaders in the world of genomics, health, and data sharing.
Check out our videos, then subscribe to our YouTube channel for more content.
View the latest GA4GH updates, Genomics and Health News, Implementation Notes, GDPR Briefs, and more.
Discover all things GA4GH: explore our news, events, videos, podcasts, announcements, publications, and newsletters.
20 Jun 2024
The Victor Phillip Dahdaleh Institute of Genomic Medicine at McGill University joins the Ontario Institute for Cancer Research (OICR), the Broad Institute of MIT and Harvard, the Wellcome Sanger Institute, and EMBL’s European Bioinformatics Institute (EMBL-EBI) as a fifth host institution of the Global Alliance for Genomics and Health (GA4GH).
By Jaclyn Estrin, GA4GH Science Writer
The Global Alliance for Genomics and Health (GA4GH) is pleased to welcome the Victor Phillip Dahdaleh Institute of Genomic Medicine at McGill University as a fifth GA4GH Host Institution.
The Victor Phillip Dahdaleh Institute of Genomic Medicine at McGill University was founded in the Fall of 2022, with a vision of “applying genomic innovation to pave the way towards a healthier, more sustainable, and informed future.”
McGill University is a significant contributor of innovations in the field of genomics, including through its recent ground-breaking research initiative DNA to RNA (D2R), supported by the Canada First Research Excellence Fund, that will contribute to developing revolutionary genomic-based RNA medicines.
McGill’s Victor Phillip Dahdaleh Institute of Genomic Medicine joins the ranks of the four existing GA4GH Host Institutions: the Ontario Institute for Cancer Research (OICR), the Broad Institute of MIT and Harvard, the Wellcome Sanger Institute, and EMBL’s European Bioinformatics Institute (EMBL-EBI). Host Institutions help enable the work of GA4GH by providing services, staff, space, and grant management.
GA4GH has established a Memorandum of Understanding (MoU) among its five Host Institutions. While the MoU is not a binding agreement, it outlines the understood expectations, roles, and responsibilities Host Institutions have in supporting the achievement of GA4GH’s strategic vision. This agreement shapes how the Host Institutions engage with GA4GH Inc., the GA4GH not-for-profit organisation based in Canada, and with each other.
Since its inception, GA4GH has benefitted from a long-standing collaboration with the Centre of Genomics and Policy (CGP) at McGill University, now housed within McGill’s Victor Phillip Dahdaleh Institute of Genomic Medicine. The CGP is an interdisciplinary research centre at the crossroads of law, medicine, bioethics, and public policy. It has been pivotal in supporting the work of the GA4GH Regulatory & Ethics Work Stream (REWS), which develops guidance on the ethical, legal, and social issues that arise within genomic research and international data sharing.
CGP Director Yann Joly said, “The collaboration between the CGP and GA4GH led to the development of the Framework for responsible sharing of genomic and health-related data [Framework], a human rights landmark for the international genomics and biomedical research communities.”
Founding Director of the CGP Bartha Maria Knoppers, who was fundamental in leading the development of the GA4GH Framework, added, “This unique international endeavour is founded on the human right of everyone to benefit from science. It needs to prospectively provide the policies and tools for sharing and linking genomic and health data.”
The Canadian Centre for Computational Genomics (C3G), also part of the Victor Phillip Dahdaleh Institute of Genomic Medicine, has been another significant contributor to GA4GH over the past years. C3G is actively involved in the Discovery Work Stream and Clinical & Phenotypic Data Capture (Clin/Pheno) Work Stream, developing technical standards aiming to facilitate data sharing across initiatives.
Mark Lathrop, Director of the Victor Phillip Dahdaleh Institute of Genomic Medicine at McGill, said, “GA4GH is the most important initiative for responsible use of genomic data to benefit everyone worldwide. We are very proud of the contributions being made by the McGill CGP and other Institute investigators to its success.”
The establishment of the Victor Phillip Dahdaleh Institute of Genomic Medicine provided an opening for a more formalised relationship with the CGP, C3G, and McGill, through a Host Institution designation. Chief Executive Officer of GA4GH and President of GA4GH Inc. Peter Goodhand said, “CGP has been the home and the heart of our REWS efforts from the very beginning. The formal relationship will open doors to building strong relationships with McGill’s bioinformatics teams and engage them more directly in technical standards development.”
The addition of this new Host Institution will help accelerate and expand the work of REWS, as well as tap into several technical communities, including two GA4GH Driver Projects: The Pan-Canadian Genomic Library (PCGL), which aims to facilitate responsible genomic data sharing across Canada, and EpiShare, an open science project that makes epigenomic datasets more accessible.
Goodhand said, “From the beginning, CGP has been integral to everything we have done over the last ten years, and we are happy to formally recognise the Victor Phillip Dahdaleh Institute of Genomic Medicine as the fifth of our Host Institutions.”
Joly added, “This new arrangement will allow the Victor Phillip Dahdaleh Institute of Genomic Medicine’s CGP and C3G to work in an even more integrated manner with GA4GH, which bodes well for the future of genomic data sharing.’’